NRIX Competitors & Alternatives
Compare Nurix Therapeutics Inc with similar stocks in the same industry
Biotechnology
NRIX
Main Stock$15.94
Tradestie Score
56
Market Cap
$718.62M
Revenue Growth
-0.7%
Analyst Upside
+89.7%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$17.65
|
$1.74B | - | 58 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$32.38
|
$1.68B | - | 55 | Compare |
|
MNKD
Mannkind Corporation
|
$3.20
|
$1.65B | - | 59 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$32.93
|
$1.63B | - | 61 | Compare |
|
BHVN
Biohaven Ltd.
|
$9.15
|
$1.57B | - | 57 | Compare |
|
VCEL
Vericel Corporation
|
$32.92
|
$1.56B | 76.6 | 59 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$85.64
|
$1.55B | - | 59 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$31.17
|
$1.55B | 12.2 | 57 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$32.26
|
$1.55B | - | 68 | Compare |
|
NVAX
Novavax Inc
|
$9.02
|
$1.54B | - | 58 | Compare |
More NRIX Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry